A glycoprotein associated with the non-A, non-B hepatitis agent(s): isolation and immunoreactivitySETO, B; GERETY, R. J.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 15, pp 4934-4938, issn 0027-8424Article

Key issues in the selection of an expression system for vaccine antigensELLIS, R. W; GERETY, R. J.Journal of medical virology. 1990, Vol 31, Num 1, pp 54-58, issn 0146-6615, 5 p.Article

Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B, and non-A, non-B hepatitisTABOR, E; PURCELL, R. H; GERETY, R. J et al.Journal of medical primatology. 1983, Vol 12, Num 6, pp 305-318, issn 0047-2565Article

Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technologyHILLEMAN, M. R; GERETY, R. J; ELLIS, R. W et al.Developments in biological standardization. 1987, Vol 68, pp 5-7, issn 0301-5149Article

New findings in live, attenuated hepatitis A vaccine developmentPROVOST, P. J; BISHOP, R. P; GERETY, R. J et al.Journal of medical virology. 1986, Vol 20, Num 2, pp 165-175, issn 0146-6615Article

Additional evidence for more than one agent of human non-A, non-B hepatitisTABOR, E; SNOV, P; JACKSON, D. R et al.Transfusion (Philadelphia, PA). 1984, Vol 24, Num 3, pp 224-230, issn 0041-1132Article

Antibody responses of adults, adolescents, and children to a plasma-derived hepatitis B vaccine in a rural African settingTABOR, E; GERETY, R. J; CAIRNS, J et al.Journal of medical virology. 1990, Vol 32, Num 2, pp 134-138, issn 0146-6615, 5 p.Article

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzeeIWARSON, S; TABOR, E; THOMAS, H. C et al.Journal of medical virology. 1985, Vol 16, Num 1, pp 89-96, issn 0146-6615Article

Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicitySAMPLINER, R. E; WORONOW, D. I; ALTER, M. J et al.Journal of medical virology. 1984, Vol 13, Num 2, pp 125-130, issn 0146-6615Article

Protective effect of a synthetic peptide comprising the complete PreS2 region of the hepatitis B virus surface proteinEMINI, E. A; LARSON, V; EICHBERG, J et al.Journal of medical virology. 1989, Vol 28, Num 1, pp 7-12, issn 0146-6615Article

Successful postexposure vaccination against hepatitis B in chimpanzeesIWARSON, S; WAHL, M; RUTTIMAN, E et al.Journal of medical virology. 1988, Vol 25, Num 4, pp 433-439, issn 0146-6615Article

Detection of reverse transcriptase activity in association with the non-A, non-B hepatitis agent(s)SETO, B; COLEMAN, W. G. JR; IWARSON, S et al.Lancet (British edition). 1984, Vol 2, Num 8409, pp 941-943, issn 0140-6736Article

Failure of hepatitis B immune globulin to protect against exp infection in chimpanzeesWAHL, M; IWARSON, S; SNOY, P et al.Journal of hepatology. 1989, Vol 9, Num 2, pp 198-203, issn 0168-8278Article

Human recombinant soluble CD4 therapyGERETY, R. J; HANSON, D. G; THOMAS, D. W et al.Lancet (British edition). 1989, Num 8678/8679, issn 0140-6736, 1521[1p.]Article

Concomitant hepatitis B surface antigen and antibody in thirteen patientsFOUTCH, P. G; CAREY, W. D; TABOR, E et al.Annals of internal medicine. 1983, Vol 99, Num 4, pp 460-463, issn 0003-4819Article

Nine-year follow-up study of a plasma-derived hepatitis B vaccine in a rural African settingTABOR, E; CAIRNS, J; GERETY, R. J et al.Journal of medical virology. 1993, Vol 40, Num 3, pp 204-209, issn 0146-6615Article

Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB)VELLA, P. P; STAUB, J. M; TOLMAN, R. L et al.Pediatrics (Evanston). 1990, Vol 85, Num 4, pp 668-675, issn 0031-4005, 2Article

Chromatographic removal of hepatitis B virus from a factor IX concentrate. Experimental studies in chimpanzeesIWARSON, S; EINARSSON, M; SMALLWOOD, L et al.Transfusion (Philadelphia, PA). 1987, Vol 27, Num 2, pp 171-173, issn 0041-1132Article

Horizontal transmission of hepatitis B virus among children and adults in five rural villages in ZambiaTABOR, E; BAYLEY, A. C; CAIRNS, J et al.Journal of medical virology. 1985, Vol 15, Num 2, pp 113-120, issn 0146-6615Article

Serologic markers of hepatitis A and B in the population of Bali, IndonesiaBROWN, P; BREGUET, G; SMALLWOOD, L et al.The American journal of tropical medicine and hygiene. 1985, Vol 34, Num 3, pp 616-619, issn 0002-9637Article

Ultrastructural alterations in serial liver biopsy specimens from chimpanzees experimentally infectee with a human non-A, non-B hepatitis agentSCHAFF, Z; TABOR, E; JACKSON, D. R et al.Virchows Archiv. A, Pathological anatomy and histology. 1984, Vol 45, Num 3, pp 301-312, issn 0340-1227Article

Varicella vaccine (VARIVAX) in healthy children and adolescents : results from clinical trials, 1987 to 1989JO WHITE, C; KUTER, B. J; HILDEBRAND, C. S et al.Pediatrics (Evanston). 1991, Vol 87, Num 5, pp 604-610, issn 0031-4005Article

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1- abolishes infectivity for chimpanzeesEMINI, E. A; NARA, P. L; GERETY, R. J et al.Journal of virology. 1990, Vol 64, Num 8, pp 3674-3678, issn 0022-538X, 5 p.Article

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB) : clinical evaluationAHONKHAI, V. I; LUKACS, L. J; GERETY, R. J et al.Pediatrics (Evanston). 1990, Vol 85, Num 4, pp 676-681, issn 0031-4005, 2Article

Protection against hepatitis B virus infection by immunization with hepatitis B core antigenIWARSON, S; TABOR, E; THOMAS, H. C et al.Gastroenterology (New York, NY. 1943). 1985, Vol 88, Num 3, pp 763-767, issn 0016-5085Article